Identification of novel candidate risk genes for myelomeningocele within the glucose homeostasis/oxidative stress and folate/one-carbon metabolism networks.
Myelomeningocele
exome sequencing
folate
glucose
mutation burden
Journal
Molecular genetics & genomic medicine
ISSN: 2324-9269
Titre abrégé: Mol Genet Genomic Med
Pays: United States
ID NLM: 101603758
Informations de publication
Date de publication:
11 2020
11 2020
Historique:
received:
01
05
2020
revised:
17
07
2020
accepted:
05
08
2020
pubmed:
23
9
2020
medline:
8
6
2021
entrez:
22
9
2020
Statut:
ppublish
Résumé
Neural tube defects (NTDs) are the second most common complex birth defect, yet, our understanding of the genetic contribution to their development remains incomplete. Two environmental factors associated with NTDs are Folate and One Carbon Metabolism (FOCM) and Glucose Homeostasis and Oxidative Stress (GHOS). Utilizing next-generation sequencing of a large patient cohort, we identify novel candidate genes in these two networks to provide insights into NTD mechanisms. Exome sequencing (ES) was performed in 511 patients, born with myelomeningocele, divided between European American and Mexican American ethnicities. Healthy control data from the Genome Aggregation database were ethnically matched and used as controls. Rare, high fidelity, nonsynonymous predicted damaging missense, nonsense, or canonical splice site variants in independently generated candidate gene lists for FOCM and GHOS were identified. We used a gene-based collapsing approach to quantify mutational burden in case and controls, with the control cohort estimated using cumulative allele frequencies assuming Hardy-Weinberg equilibrium. We identified 45 of 837 genes in the FOCM network and 22 of 568 genes in the GHOS network as possible NTD risk genes with p < 0.05. No nominally significant risk genes were shared between ethnicities. Using a novel approach to mutational burden we identify 55 novel NTD risk associations. We provide a means of utilizing large publicly available sequencing datasets as controls for sequencing projects examining rare disease. This approach confirmed existing risk genes for myelomeningocele and identified possible novel risk genes. Lastly, it suggests possible distinct genetic etiologies for this malformation between different ethnicities.
Sections du résumé
BACKGROUND
Neural tube defects (NTDs) are the second most common complex birth defect, yet, our understanding of the genetic contribution to their development remains incomplete. Two environmental factors associated with NTDs are Folate and One Carbon Metabolism (FOCM) and Glucose Homeostasis and Oxidative Stress (GHOS). Utilizing next-generation sequencing of a large patient cohort, we identify novel candidate genes in these two networks to provide insights into NTD mechanisms.
METHODS
Exome sequencing (ES) was performed in 511 patients, born with myelomeningocele, divided between European American and Mexican American ethnicities. Healthy control data from the Genome Aggregation database were ethnically matched and used as controls. Rare, high fidelity, nonsynonymous predicted damaging missense, nonsense, or canonical splice site variants in independently generated candidate gene lists for FOCM and GHOS were identified. We used a gene-based collapsing approach to quantify mutational burden in case and controls, with the control cohort estimated using cumulative allele frequencies assuming Hardy-Weinberg equilibrium.
RESULTS
We identified 45 of 837 genes in the FOCM network and 22 of 568 genes in the GHOS network as possible NTD risk genes with p < 0.05. No nominally significant risk genes were shared between ethnicities. Using a novel approach to mutational burden we identify 55 novel NTD risk associations.
CONCLUSIONS
We provide a means of utilizing large publicly available sequencing datasets as controls for sequencing projects examining rare disease. This approach confirmed existing risk genes for myelomeningocele and identified possible novel risk genes. Lastly, it suggests possible distinct genetic etiologies for this malformation between different ethnicities.
Identifiants
pubmed: 32960507
doi: 10.1002/mgg3.1495
pmc: PMC7667334
doi:
Substances chimiques
Folic Acid
935E97BOY8
Glucose
IY9XDZ35W2
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
e1495Subventions
Organisme : NICHD NIH HHS
ID : R01 HD073434
Pays : United States
Informations de copyright
© 2020 The Authors. Molecular Genetics & Genomic Medicine published by Wiley Periodicals LLC.
Références
JAMA. 2015 Sep 8;314(10):1021-9
pubmed: 26348752
Nucleic Acids Res. 2019 Jan 8;47(D1):D801-D806
pubmed: 30407599
JAMA. 2009 Feb 11;301(6):636-50
pubmed: 19211471
Birth Defects Res A Clin Mol Teratol. 2012 Sep;94(9):683-92
pubmed: 22806986
Am J Physiol Endocrinol Metab. 2013 Sep 1;305(5):E667-78
pubmed: 23880312
Nature. 2016 Aug 17;536(7616):285-91
pubmed: 27535533
Clin Anat. 2017 Oct;30(7):988-999
pubmed: 28795440
Adv Nutr. 2012 Jan;3(1):21-38
pubmed: 22332098
Dev Disabil Res Rev. 2010;16(1):6-15
pubmed: 20419766
Curr Top Dev Biol. 2008;84:1-35
pubmed: 19186242
Reprod Sci. 2008 Jan;15(1):51-8
pubmed: 18212354
J Proteome Res. 2014 Feb 7;13(2):934-45
pubmed: 24397701
Am J Med Genet A. 2017 Nov;173(11):3042-3057
pubmed: 28944587
Birth Defects Res A Clin Mol Teratol. 2009 Apr;85(4):295-302
pubmed: 19301298
World J Diabetes. 2015 Apr 15;6(3):481-8
pubmed: 25897357
Birth Defects Res A Clin Mol Teratol. 2008 Jul;82(7):527-32
pubmed: 18481813
Birth Defects Res. 2017 Jan 30;109(2):99-105
pubmed: 27384413
MMWR Morb Mortal Wkly Rep. 2017 Jan 20;66(2):41-46
pubmed: 28103210
Paediatr Perinat Epidemiol. 2019 Mar;33(2):145-153
pubmed: 30920008
Am J Obstet Gynecol. 2016 Feb;214(2):192-202
pubmed: 26432466
Annu Rev Neurosci. 2014;37:221-42
pubmed: 25032496
Am J Med Genet C Semin Med Genet. 2005 May 15;135C(1):69-76
pubmed: 15800854
Reprod Toxicol. 2018 Sep;80:92-104
pubmed: 29859881
MMWR Morb Mortal Wkly Rep. 2015 Jan 16;64(1):1-5
pubmed: 25590678
Genet Med. 2015 May;17(5):405-24
pubmed: 25741868
J Nutr Biochem. 2011 Dec;22(12):1172-7
pubmed: 21333513
Nucleic Acids Res. 2019 Jan 8;47(D1):D886-D894
pubmed: 30371827
Nucleic Acids Res. 2018 Jan 4;46(D1):D754-D761
pubmed: 29155950
Am J Epidemiol. 2010 Feb 15;171(4):407-14
pubmed: 20042435
Congenit Anom (Kyoto). 2017 Sep;57(5):138-141
pubmed: 28603928
Ann N Y Acad Sci. 2018 Feb;1414(1):31-46
pubmed: 29363759
Birth Defects Res A Clin Mol Teratol. 2008 Oct;82(10):692-700
pubmed: 18937358
Hum Mutat. 2016 Mar;37(3):235-41
pubmed: 26555599
Am J Hum Genet. 2018 Oct 4;103(4):522-534
pubmed: 30269813
Nucleic Acids Res. 2019 Jan 8;47(D1):D330-D338
pubmed: 30395331
PLoS One. 2016 Apr 11;11(4):e0151586
pubmed: 27064786
Am J Obstet Gynecol. 2015 May;212(5):569-79
pubmed: 25434839
Am J Obstet Gynecol. 2008 Sep;199(3):237.e1-9
pubmed: 18674752
Lancet. 1991 Jul 20;338(8760):131-7
pubmed: 1677062